Ingersoll Rand Acquires Dave Barry Plastics to Expand Life Sciences Portfolio

Ingersoll Rand has acquired Dave Barry Plastics to expand its life sciences portfolio. Dave Barry Plastics designs and manufactures plastic product solutions for the life science and healthcare technology industries. The acquisition was announced on Monday and the stock price of Ingersoll Rand increased 1.22% to $75.9 premarket.

Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Dave Barry Plastics to further expand its life sciences portfolio. The acquisition was announced on Monday and saw the stock price of Ingersoll Rand increase by 1.22% to $75.9 premarket.

Dave Barry Plastics, an Ireland-based manufacturer, specializes in designing and manufacturing plastic product solutions for the life science and healthcare technology industries. These solutions, which include clean room solutions, are designed to minimize contamination risks during manufacturing, packaging, and storage processes. The acquisition aligns with Ingersoll Rand's growth strategy, focusing on innovation and market expansion within the life sciences sector.

The acquisition was completed at a purchase multiple of approximately 9x 2024 Adjusted EBITDA [1]. Vicente Reynal, chairman and chief executive officer of Ingersoll Rand, stated, "The acquisition of Dave Barry Plastics reflects our commitment to expanding our portfolio with innovative, high-performance solutions. Their expertise in custom plastic products for the biopharmaceutical, pharmaceutical, and medical device industries will greatly enhance Ingersoll Rand’s life science capabilities."

Dave Barry Plastics will join the Life Sciences platform within the Precision and Science Technologies (P&ST) segment of Ingersoll Rand. This strategic move is expected to drive growth through purposeful, direct investments and strengthen Ingersoll Rand's position in the life sciences market.

The acquisition is part of Ingersoll Rand's broader strategy to acquire family-owned businesses on a proprietary basis, driven by strong relationships and cultivation efforts [2]. This approach has proven successful in the past, with the company demonstrating its ability to integrate acquired businesses effectively.

Forward-looking statements in the news release indicate that Ingersoll Rand expects the acquisition to contribute to its long-term value creation and market expansion. However, the company acknowledges potential risks and uncertainties, including geopolitical tensions, cyber events, and evolving legal and regulatory regimes.

For more information about Ingersoll Rand Inc., visit [www.IRCO.com](http://www.IRCO.com).

References:
[1] https://www.globenewswire.com/news-release/2025/08/04/3126558/0/en/Ingersoll-Rand-Expands-Life-Sciences-Portfolio-with-Acquisition-of-Dave-Barry-Plastics.html
[2] https://www.stocktitan.net/news/IR/ingersoll-rand-expands-life-sciences-portfolio-with-acquisition-of-hlp6vvo01lbo.html